Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi-institutional Experience and Review of the Literature-Reference-Cited by-同舟云学术

Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi-institutional Experience and Review of the Literature

Published:2018-10 Issue:10 Volume:18 Page:e427-e435
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Broadwater Devin R.,Conant Joanna L.,Czuchlewski David R.,Hall Jordan M.,Wei Shi,Siegal Gene P.,Peker Deniz

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues;Swerdlow,2017

2. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163;Vos;Mod Pathol,2005

3. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy;Hornick;Am J Surg Pathol,2004

4. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases;Pileri;Histopathology,2002

5. Hematologic neoplasia associated with primary mediastinal germ-cell tumors;Nichols;N Engl J Med,1990

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transdifferentiation of high-grade B-cell lymphoma with MYC and BCL2 rearrangements into histiocytic sarcoma after CAR T-cell therapy: a case report;Journal of Hematopathology;2022-10-21

2. Successful Treatment of Incidental Histiocytic Sarcoma Concomitant with Laryngeal Carcinoma;Internal Medicine;2021-08-15

3. Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016;Vnitřní lékařství;2020-10-08

4. Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature;Clinical Lymphoma Myeloma and Leukemia;2019-01